Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.
2.

DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies.

Foroni L, Catovsky D, Rabbitts TH, Luzzatto L.

Mol Biol Med. 1984 Feb;2(1):63-79.

PMID:
6439975
4.

Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody.

Huh YO, Pugh WC, Kantarjian HM, Stass SA, Cork A, Trujillo JM, Keating MJ.

Am J Clin Pathol. 1994 Mar;101(3):283-9.

PMID:
8135183
5.

Emergence of a B-cell lymphoblastic lymphoma in a patient with B-cell chronic lymphocytic leukemia: evidence for the single-cell origin of the two tumors.

Pistoia V, Roncella S, Di Celle PF, Sessarego M, Cutrona G, Cerruti G, Boccaccio GP, Grossi CE, Foà R, Ferrarini M.

Blood. 1991 Aug 1;78(3):797-804.

6.

IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.

Wakai M, Hashimoto S, Omata M, Sthoeger ZM, Allen SL, Lichtman SM, Schulman P, Vinciguerra VP, Diamond B, Dono M, et al.

Autoimmunity. 1994;19(1):39-48.

PMID:
7538331
7.

An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.

Alfarano A, Indraccolo S, Circosta P, Minuzzo S, Vallario A, Zamarchi R, Fregonese A, Calderazzo F, Faldella A, Aragno M, Camaschella C, Amadori A, Caligaris-Cappio F.

Blood. 1999 Apr 1;93(7):2327-35.

8.
9.

Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.

Nelson BP, Variakojis D, Peterson LC.

Mod Pathol. 2002 Nov;15(11):1111-20.

10.

Biology of the neoplastic lymphocyte in B-CLL.

Dighiero G.

Baillieres Clin Haematol. 1993 Dec;6(4):807-20. Review.

PMID:
8038491
11.

Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.

Hashimoto S, Dono M, Wakai M, Allen SL, Lichtman SM, Schulman P, Vinciguerra VP, Ferrarini M, Silver J, Chiorazzi N.

J Exp Med. 1995 Apr 1;181(4):1507-17.

13.

Immunophenotypic and genotypic characterization of B-cell chronic lymphocytic leukemia patients from northern Italy.

Gandini D, Lanza F, Latorraca A, Levato F, Del Senno L, Castoldi G.

Haematologica. 1993 Jan-Feb;78(1):18-24.

PMID:
8491418
14.
15.

Cytokines and Epstein Barr virus (EBV) genes expression in blood chronic lymphocytic leukaemia (CLL) cells and their immortalised CLL cell lines.

Laytragoon-Lewin N, Chen F, Castro J, Avila-Carino J, Lewin F.

Anticancer Res. 2003 Sep-Oct;23(5A):4017-22.

PMID:
14666712
16.

Induction of differentiation of B-cell leukemia cell lines JVM-2 and EHEB by bryostatin 1.

Hu ZB, Gignac SM, Uphoff CC, Quentmeier H, Steube KG, Drexler HG.

Leuk Lymphoma. 1993 May;10(1-2):135-42.

PMID:
8374521
17.

B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.

Cohen JH, Revillard JP, Magaud JP, Lenoir G, Vuillaume M, Manel AM, Vincent C, Bryon PA.

J Natl Cancer Inst. 1987 Feb;78(2):235-42.

PMID:
3027441
18.

Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.

Golay J, Luppi M, Songia S, Palvarini C, Lombardi L, Aiello A, Delia D, Lam K, Crawford DH, Biondi A, Barbui T, Rambaldi A, Introna M.

Blood. 1996 Mar 1;87(5):1900-11.

19.

Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype.

Segel GB, Woodlock TJ, Xu J, Li L, Felgar RE, Ryan DH, Lichtman MA, Wang N.

Blood Cells Mol Dis. 2003 May-Jun;30(3):277-87.

PMID:
12737946
20.

Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement.

Melo JV, Brito-Babapulle V, Foroni L, Robinson DS, Luzzatto L, Catovsky D.

Int J Cancer. 1986 Oct 15;38(4):531-8.

PMID:
3093393

Supplemental Content

Support Center